Steward Financial Group’s Emergent Biosolutions EBS Stock Holding History

Steward Financial Group’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-26	Closed	–	–	446
2022 Q2	$0	Buy	+26	New	+$888	﹤0.01%	1076

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Steward Financial Group's EBS Position: Q3 2022 in Review

Steward Financial Group sold out of Emergent Biosolutions (EBS) in Q3 2022, closing a stake of 26 shares.

Steward Financial Group first reported a position in EBS in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 211 funds tracked by Wall St. Rank hold EBS as of Q3 2022.

Steward Financial Group reported no remaining Emergent Biosolutions position as of Q3 2022 after selling out during the quarter.
Steward Financial Group sold 26 Emergent Biosolutions shares in Q3 2022.
Steward Financial Group first reported a position in Emergent Biosolutions in Q2 2022 and held it in 1 quarter.
Steward Financial Group's Emergent Biosolutions position peaked at $0 in Q2 2022.
211 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2022.

Based on Steward Financial Group's 13F filing for Q3 2022, filed 7 Nov 2022.